ERBB2 and breast cancer: Therefore, we evaluated in vitro their cytotoxicity (vs. 4D5.2-MMAF) on two human breast cancer cell lines: SK-BR-3 (HER2 high expression) and MDA-MB-231 (HER2 low expression).